Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
Lübbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dörken B, Herrmann F, Gürtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke AJ, Ohlendorf D, Huhnt W, Huhn D.
Lübbe AS, et al. Among authors: dorken b.
Cancer Res. 1996 Oct 15;56(20):4686-93.
Cancer Res. 1996.
PMID: 8840985
Clinical Trial.